Impact of the ALLHAT/JNC7 Dissemination Project on thiazide-type diuretic use.

نویسندگان

  • Randall S Stafford
  • L Kay Bartholomew
  • William C Cushman
  • Jeffrey A Cutler
  • Barry R Davis
  • Glenna Dawson
  • Paula T Einhorn
  • Curt D Furberg
  • Linda B Piller
  • Sara L Pressel
  • Paul K Whelton
چکیده

BACKGROUND Strategies are needed to improve the translation of clinical trial results into practice. We assessed the impact of the ALLHAT/JNC7 Dissemination Project's academic detailing component on thiazide-type diuretic prescribing (ALLHAT indicates Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial; JNC7 indicates the Seventh Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure). METHODS We used 2 national databases available from IMS Health: a physician survey of medications reported for hypertension and a pharmacy dispensing database on antihypertensive medications. At a county level, we correlated medication data with Dissemination Project intensity. Practices before the Dissemination Project in 2004 were compared with those after its completion in 2007. We also examined 2000-2008 national trends. RESULTS Academic detailing reached 18 524 physicians in 1698 venues via 147 investigator-educators. We noted an association between ALLHAT/JNC7 academic detailing activities and increased prescribing of thiazide-type diuretics. Physician survey data showed that the percentage of hypertension visits where the physician recorded a thiazide-type diuretic increased the most in counties where academic detailing activity was the highest (an increase of 8.6%, from 37.9% to 46.5%) compared with counties where activity was moderate (an increase of 2%) or low (a decrease of 2%), or where there was none (an increase of 2%; P value for trend, <.05). Pharmacy dispensing data showed that thiazide-type diuretic prescribing increased by 8.7% in counties with Dissemination Project activities compared with 3.9% in those without activities (P < .001). Nationally, thiazide-type diuretic use did not increase between 2004 and 2008. CONCLUSIONS The ALLHAT/JNC7 Dissemination Project was associated with a small effect on thiazide-type diuretic use consistent with its small dose and the potential of external factors to diminish its impact. Academic detailing may increase physicians' implementation of clinical trial results, thereby making prescribing more consistent with evidence.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute.

There are 70-million hypertensive individuals in the United States, and 45-million persons take antihypertensive medications.1,2 Despite the results of the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT), other trials, and the recommendations in the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blo...

متن کامل

Drug notes Bendroflumethiazide

COPYRIGHT © 2013 JOHN WILEY & SONS Introduction Hypertension is common in people with diabetes. While ACE-inhibitors (ACE-Is) and angiotensin II receptor antagonists remain first-line antihypertensive agents, adequate blood pressure (BP) reduction may require two or three drugs including thiazide-like diuretics. Chlorthalidone was the diuretic used in several large diabetes hypertension studies...

متن کامل

Drug treatment of hypertension: implications of ALLHAT.

The presentation and publication of the primary results of the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT) has generated much interest and opinion. This is because (1) ALLHAT is the largest ever study of antihypertensive therapy; (2) ALLHAT addressed the commercially sensitive issue of appropriate first line therapy for hypertension; and (3) the initial ...

متن کامل

ALLHAT : still providing correct a nswers after 7 years Paula

Current Opinion in Cardiology 2010, 25:355–365 Purpose of review The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) is re-evaluated considering information from recent subgroup and exploratory analyses, other new clinical trials, and meta-analyses. The ALLHAT analyses specifically emphasize heart failure findings, results in Black participants and those wit...

متن کامل

Prescribing patterns for antihypertensive drugs after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: report of experience in a health maintenance organization.

BACKGROUND The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) reported that primary cardiovascular outcomes were the same in hypertensive patients treated with thiazide-type diuretics as in those treated with calcium channel blockers or angiotensin-converting enzyme inhibitors. The aim of this study was to assess prescribing patterns of antihypertensive age...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Archives of internal medicine

دوره 170 10  شماره 

صفحات  -

تاریخ انتشار 2010